First City Capital Management, Inc. Gilead Sciences, Inc. Transaction History

First City Capital Management, Inc.

$175 Million
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$77.31 - $88.08 $2,473 - $2,818	-32 Reduced 1.28%	2,477 $205,000
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $156,360 - $224,480	2,509 New	2,509 $215,000
Q4 2021 Feb 07, 2022	SELL	$64.88 - $73.64 $196,391 - $222,908	-3,027 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$67.69 - $73.03 $13,538 - $14,606	-200 Reduced 6.2%	3,027 $211,000
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $193,620 - $220,920	3,227 New	3,227 $218,000
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $308,515 - $351,539	-5,446 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $118,114 - $148,508	1,902 Added 53.67%	5,446 $344,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $25,319 - $29,400	350 Added 10.96%	3,544 $273,000
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $18,789 - $24,066	-300 Reduced 8.59%	3,194 $239,000
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $106,787 - $117,462	-1,733 Reduced 33.15%	3,494 $227,000
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $93,765 - $103,500	-1,500 Reduced 22.3%	5,227 $331,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $6,187 - $6,938	100 Added 1.51%	6,727 $454,000
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $96,921 - $108,577	-1,550 Reduced 18.96%	6,627 $431,000
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $148,323 - $193,550	-2,450 Reduced 23.05%	8,177 $511,000
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $78,408 - $86,812	1,100 Added 11.55%	10,627 $821,000
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $6,488 - $7,568	-100 Reduced 1.04%	9,527 $675,000
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $74,707 - $87,696	-1,050 Reduced 9.83%	9,627 $690,000
Q3 2017 Oct 31, 2017	SELL	$72.11 - $85.47 $10,816 - $12,820	-150 Reduced 1.39%	10,677 $865,000
Q2 2017 Aug 14, 2017	BUY	N/A	10,827	10,827 $766,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First City Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First City Capital Management, Inc. with notifications on news.

Account